Ginkgo Bioworks (DNA, Financial) is set to enhance laboratory automation at Aura Genetics, a leading diagnostic laboratory, through the deployment of its Reconfigurable Automation Cart (RAC) system. This innovative solution will be implemented at Aura Genetics' newly established 22,000-square-foot facility, strategically located at the UPS Healthcare Labport near the Louisville, KY airport.
The RAC system, which features modular capabilities, will be integrated with Ginkgo Automation's advanced orchestration software and real-time error resolution services. This integration is designed to optimize and expand Aura Genetics' diagnostic testing processes, aligning with the increasing demand in the at-home testing and wellness sector.
By leveraging the expertise of Ginkgo's automation engineers and scientists, Aura Genetics aims to achieve the capacity to handle tens of thousands of samples daily. This strategic enhancement is expected to significantly improve the efficiency and scalability of Aura Genetics' operations, catering to the growing needs of the healthcare industry.
Wall Street Analysts Forecast
Based on the one-year price targets offered by 5 analysts, the average target price for Ginkgo Bioworks Holdings Inc (DNA, Financial) is $8.30 with a high estimate of $12.00 and a low estimate of $5.50. The average target implies an upside of 13.08% from the current price of $7.34. More detailed estimate data can be found on the Ginkgo Bioworks Holdings Inc (DNA) Forecast page.
Based on the consensus recommendation from 6 brokerage firms, Ginkgo Bioworks Holdings Inc's (DNA, Financial) average brokerage recommendation is currently 3.8, indicating "Underperform" status. The rating scale ranges from 1 to 5, where 1 signifies Strong Buy, and 5 denotes Sell.
Based on GuruFocus estimates, the estimated GF Value for Ginkgo Bioworks Holdings Inc (DNA, Financial) in one year is $25.62, suggesting a upside of 249.05% from the current price of $7.34. GF Value is GuruFocus' estimate of the fair value that the stock should be traded at. It is calculated based on the historical multiples the stock has traded at previously, as well as past business growth and the future estimates of the business' performance. More detailed data can be found on the Ginkgo Bioworks Holdings Inc (DNA) Summary page.
